Elective Switching on Biosimilars: Far More Than Nonmedical Switching

Xiaocang Cao¹, Haibin Yuan^{2

3}, Jie Liang⁴, He Huang^{2

3

5}

Affiliations

¹ Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
² Department of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
³ Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, China.
⁴ Department of Gastroenterology and Hepatology, Xijing Hospital, Xi'an, China.
⁵ Institute of Shaoxing, Tianjin University, Zhejiang, China.

Xiaocang Cao et al. Inflamm Bowel Dis. 2022.

. 2022 Jul 1;28(7):e101-e102.

doi: 10.1093/ibd/izac007.

Xiaocang Cao¹, Haibin Yuan^{2

3}, Jie Liang⁴, He Huang^{2

3

5}

¹ Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
² Department of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
³ Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, China.
⁴ Department of Gastroenterology and Hepatology, Xijing Hospital, Xi'an, China.
⁵ Institute of Shaoxing, Tianjin University, Zhejiang, China.

No abstract available

Keywords: allergic; biosimilars; inflammatory bowel diseases.

Publication types